fluorobenzenes has been researched along with Depressive Disorder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, A; Anwer, L; Asghar, S; Munawar, R; Mushtaq, N; Ul-Haq, Z; Usmani, S | 1 |
| Bhagwagar, Z; Cowen, P; Fancy, S; Grasby, P; Hinz, R; Taylor, M | 1 |
2 other study(ies) available for fluorobenzenes and Depressive Disorder
| Article | Year |
|---|---|
Computation-based experimentation: Identification of piperazine containing antidepressants.
Topics: Antidepressive Agents; Blood-Brain Barrier; Computer Simulation; Depressive Disorder; Drug Evaluation, Preclinical; Fluorobenzenes; In Vitro Techniques; Molecular Docking Simulation; Monoamine Oxidase Inhibitors; Piperazines; Quantitative Structure-Activity Relationship | 2021 |
Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907.
Topics: Adult; Attitude; Carbon Radioisotopes; Cerebellum; Cerebral Cortex; Depressive Disorder; Female; Fluorobenzenes; Humans; Male; Personality Inventory; Piperidines; Positron-Emission Tomography; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT2A; Recurrence; Tissue Distribution | 2006 |